CLINICOR INC
10QSB, EX-27, 2000-08-10
TESTING LABORATORIES
Previous: CLINICOR INC, 10QSB, 2000-08-10
Next: WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP, 10-Q, 2000-08-10



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CLINICOR,
INC. FINANCIAL STATEMENTS AS OF JUNE 30, 2000, AND FOR THE 3- AND 6-MONTH
PERIODS ENDED JUNE 30, 2000, AND THE ACCOMPANYING NOTES AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                       DEC-31-2000          DEC-31-2000
<PERIOD-START>                          APR-01-2000          JAN-01-2000
<PERIOD-END>                            JUN-30-2000          JUN-30-2000
<CASH>                                       29,436               29,436
<SECURITIES>                                      0                    0
<RECEIVABLES>                             1,215,408            1,215,408
<ALLOWANCES>                                 20,000               20,000
<INVENTORY>                                       0                    0
<CURRENT-ASSETS>                          1,544,210            1,544,210
<PP&E>                                    1,968,656            1,968,656
<DEPRECIATION>                            1,036,895            1,036,895
<TOTAL-ASSETS>                            2,487,418            2,487,418
<CURRENT-LIABILITIES>                     3,904,959            3,904,959
<BONDS>                                      37,828<F1>           37,828<F1>
                             0                    0
                               9,423,000            9,423,000
<COMMON>                                      4,170                4,170
<OTHER-SE>                              (11,062,539)         (11,062,539)
<TOTAL-LIABILITY-AND-EQUITY>              2,487,418            2,487,418
<SALES>                                   1,283,219            2,691,084
<TOTAL-REVENUES>                          1,283,219            2,691,084
<CGS>                                     1,036,241            2,148,624
<TOTAL-COSTS>                             1,925,410            3,986,326
<OTHER-EXPENSES>                                  0                    0
<LOSS-PROVISION>                                  0                    0
<INTEREST-EXPENSE>                          (41,774)<F2>         (86,746)<F2>
<INCOME-PRETAX>                            (683,965)          (1,381,988)
<INCOME-TAX>                                      0                    0
<INCOME-CONTINUING>                        (683,965)          (1,381,988)
<DISCONTINUED>                                    0                    0
<EXTRAORDINARY>                                   0                    0
<CHANGES>                                         0                    0
<NET-INCOME>                               (683,965)          (1,381,988)
<EPS-BASIC>                                   (0.22)               (0.45)
<EPS-DILUTED>                                 (0.22)               (0.45)

<FN>
<F1>CONSISTS OF CAPITALIZED LEASE OBLIGATIONS, EXCLUDING CURRENT PORTIONS
<F2>NET INTEREST EXPENSE IS NET OF INTEREST REVENUE
</FN>


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission